Should all patients receive dual chamber pacing ICDs? The rationale for the DAVID trial
All of the prospective multicenter trials that support the use of implantable defibrillators have used single chamber pacemakers/implantable cardiovertor defibrillators (ICDs). Despite the significantly increased cost of dual chamber pacemaker/ICD devices and the lack of outcome data, these devices...
Bewaard in:
| Gepubliceerd in: | Curr Control Trials Cardiovasc Med |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2001
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59522/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806799/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-5-215 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|